{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:06:40Z","timestamp":1790622400530,"version":"4.1.0"},"reference-count":98,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T00:00:00Z","timestamp":1612915200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006438","name":"US Department of Health and Human Services Office of the Assistant Secretary for Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006438","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.ijid.2021.02.046","type":"journal-article","created":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T13:00:47Z","timestamp":1613739647000},"page":"505-515","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["South American Hemorrhagic Fevers: A summary for clinicians"],"prefix":"10.1016","volume":"105","author":[{"given":"Maria G.","family":"Frank","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Beitscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille M.","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Raabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Beitscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahid","family":"Bhadelia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore J.","family":"Cieslak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard T.","family":"Davey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry","family":"Dierberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared D.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria G.","family":"Frank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Grein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark G.","family":"Kortepeter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen S.","family":"Kraft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris J.","family":"Kratochvil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"McLellan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aneesh K.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Raabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Risi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Sauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica S.","family":"Shenoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Uyeki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ijid.2021.02.046_bib0005","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.3201\/eid1509.090017","article-title":"Reemergence of Bolivian hemorrhagic fever, 2007-2008","volume":"15","author":"Aguilar","year":"2009","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"10.1016\/j.ijid.2021.02.046_bib0010","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01741-19","article-title":"Monoclonal antibodies with neutralizing activity and Fc-effector functions against the Machupo virus glycoprotein","volume":"94","author":"Amanat","year":"2020","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.ijid.2021.02.046_bib0015","doi-asserted-by":"crossref","first-page":"694","DOI":"10.4161\/hv.7.6.15198","article-title":"Argentine hemorrhagic fever vaccines","volume":"7","author":"Ambrosio","year":"2011","journal-title":"Hum Vaccin"},{"issue":"1","key":"10.1016\/j.ijid.2021.02.046_bib0020","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/jmv.1890210109","article-title":"Protection of Jun\u00edn virus-infected marmosets by passive administration of immune serum: association with late neurologic signs","volume":"21","author":"Avila","year":"1987","journal-title":"J Med Virol"},{"issue":"5","key":"10.1016\/j.ijid.2021.02.046_bib0025","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1056\/NEJM199508033330505","article-title":"Brief report: treatment of a laboratory-acquired Sabia virus infection","volume":"333","author":"Barry","year":"1995","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ijid.2021.02.046_bib0030","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1177\/0300985815588609","article-title":"Pathogenesis of Bolivian hemorrhagic fever in Guinea pigs","volume":"53","author":"Bell","year":"2016","journal-title":"Vet Pathol"},{"issue":"3","key":"10.1016\/j.ijid.2021.02.046_bib0035","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000149516","article-title":"Protection conferred against Junin virus infection in rats","volume":"21","author":"Blejer","year":"1984","journal-title":"Intervirology"},{"issue":"12","key":"10.1016\/j.ijid.2021.02.046_bib0040","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2807\/esm.09.12.00504-en","article-title":"Bichat guidelines for the clinical management of haemorrhagic fever viruses and bioterrorism-related haemorrhagic fever viruses","volume":"9","author":"Bossi","year":"2004","journal-title":"Euro Surveill"},{"key":"10.1016\/j.ijid.2021.02.046_bib0045","first-page":"565","article-title":"Contagio interhumano e infeccion inaparente por virusJunin in matrimonios del area endemica de fiebre hemorragica Argentina","volume":"47","author":"Briggiler","year":"1987","journal-title":"Medicina (Buenos Aires)"},{"issue":"4","key":"10.1016\/j.ijid.2021.02.046_bib0050","doi-asserted-by":"crossref","DOI":"10.3390\/v10040199","article-title":"Role of the ERK1\/2 signaling pathway in the replication of Junin and Tacaribe viruses","volume":"10","author":"Brunetti","year":"2018","journal-title":"Viruses"},{"issue":"7","key":"10.1016\/j.ijid.2021.02.046_bib0055","doi-asserted-by":"crossref","DOI":"10.4172\/2157-7560.1000160","article-title":"Vaccine platforms to control arenaviral hemorrhagic fevers","volume":"3","author":"Carrion","year":"2012","journal-title":"J Vaccines Vaccination"},{"issue":"1","key":"10.1016\/j.ijid.2021.02.046_bib0060","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-04271-z","article-title":"Vaccine-elicited receptor-binding site antibodies neutralize two new world hemorrhagic fever arenaviruses","volume":"9","author":"Clark","year":"2018","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.ijid.2021.02.046_bib0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1001574","article-title":"Virions at the gates: receptors and the host-virus arms race","volume":"11","author":"Coffin","year":"2013","journal-title":"PLoS Biol"},{"issue":"4","key":"10.1016\/j.ijid.2021.02.046_bib0070","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.bmcl.2018.12.063","article-title":"Modified ribavirin analogues as antiviral agents against Junin virus","volume":"29","author":"Contin","year":"2019","journal-title":"Bioorg Med Chem Lett"},{"issue":"22","key":"10.1016\/j.ijid.2021.02.046_bib0075","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.1002\/asia.201900841","article-title":"New nucleoside analogues for the treatment of hemorrhagic fever virus infections","volume":"14","author":"De Clercq","year":"2019","journal-title":"Chem Asian J"},{"issue":"2","key":"10.1016\/j.ijid.2021.02.046_bib0080","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1086\/516299","article-title":"Venezuelan hemorrhagic fever: clinical and epidemiological studies of 165 cases","volume":"26","author":"de Manzione","year":"1998","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.ijid.2021.02.046_bib0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000047","article-title":"\"Chapare virus, a newly discovered arenavirus isolated from a fatal hemorrhagic fever case in Bolivia","volume":"4","author":"Delgado","year":"2008","journal-title":"PLoS Pathog"},{"issue":"4\u20136","key":"10.1016\/j.ijid.2021.02.046_bib0090","first-page":"723","article-title":"Protection of monkeys against Machupo virus by the passive administration of Bolivian haemorrhagic fever immunoglobulin (human origin)","volume":"52","author":"Eddy","year":"1975","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.ijid.2021.02.046_bib0095","series-title":"Tropical infectious diseases: principles, pathogens, and practice","first-page":"449","author":"Enr\u00eda","year":"2011"},{"issue":"3","key":"10.1016\/j.ijid.2021.02.046_bib0100","first-page":"215","article-title":"Candid#1 vaccine against Argentine hemorrhagic fever produced in Argentina. Immunogenicity and safety","volume":"70","author":"Enria","year":"2010","journal-title":"Medicina (B Aires)"},{"issue":"8397","key":"10.1016\/j.ijid.2021.02.046_bib0105","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0140-6736(84)90299-X","article-title":"Importance of dose of neutralising antibodies in treatment of Argentine haemorrhagic fever with immune plasma","volume":"2","author":"Enria","year":"1984","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ijid.2021.02.046_bib0110","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.antiviral.2007.10.010","article-title":"Treatment of Argentine hemorrhagic fever","volume":"78","author":"Enria","year":"2008","journal-title":"Antiviral Res"},{"issue":"6","key":"10.1016\/j.ijid.2021.02.046_bib0115","first-page":"615","article-title":"Late neurologic syndrome in patients with Argentinian hemorrhagic fever treated with immune plasma","volume":"45","author":"Enria","year":"1985","journal-title":"Medicina (B Aires)"},{"issue":"1","key":"10.1016\/j.ijid.2021.02.046_bib0120","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0166-3542(94)90030-2","article-title":"Antiviral treatment of Argentine hemorrhagic fever","volume":"23","author":"Enria","year":"1994","journal-title":"Antiviral Res"},{"key":"10.1016\/j.ijid.2021.02.046_bib0125","series-title":"Junin virus vaccines. Arenaviruses II: the molecular pathogenesis of Arenavirus infections","first-page":"239","author":"Enria","year":"2002"},{"key":"10.1016\/j.ijid.2021.02.046_bib0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2020.101589","article-title":"Clinical features of fatal cases of Chapare virus hemorrhagic fever originating from rural La Paz, Bolivia, 2019: a cluster analysis","author":"Escalera-Antezana","year":"2020","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.ijid.2021.02.046_bib0135","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1590\/S1020-49892005000700004","article-title":"An\u00e1lisis de la utilidad de la vacuna Candid 1 en la prevenci\u00f3n de la Fiebre Hemorr\u00e1gica Argentina en ni\u00f1os","volume":"18","author":"Feuillade","year":"2005","journal-title":"Revista Panamericana Salud P\u00fablica"},{"issue":"7","key":"10.1016\/j.ijid.2021.02.046_bib0140","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2183\/pjab.93.027","article-title":"Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase","volume":"93","author":"Furuta","year":"2017","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"issue":"1","key":"10.1016\/j.ijid.2021.02.046_bib0145","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/15428119791013080","article-title":"Sabia virus incident at Yale University","volume":"58","author":"Gandsman","year":"1997","journal-title":"Am Ind Hyg Assoc J"},{"issue":"1","key":"10.1016\/j.ijid.2021.02.046_bib0150","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-04889-x","article-title":"An attenuated Machupo virus with a disrupted L-segment intergenic region protects guinea pigs against lethal Guanarito virus infection","volume":"7","author":"Golden","year":"2017","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.ijid.2021.02.046_bib0155","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1128\/JVI.02969-15","article-title":"Glycoprotein-specific antibodies produced by DNA vaccination protect Guinea pigs from Lethal Argentine and Venezuelan Hemorrhagic Fever","volume":"90","author":"Golden","year":"2016","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.ijid.2021.02.046_bib0160","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.micinf.2010.12.006","article-title":"Junin virus. A XXI century update","volume":"13","author":"Gomez","year":"2011","journal-title":"Microbes Infect"},{"issue":"6","key":"10.1016\/j.ijid.2021.02.046_bib0165","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1128\/AAC.49.6.2378-2386.2005","article-title":"Interferon alfacon-1 protects hamsters from lethal pichinde virus infection","volume":"49","author":"Gowen","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.ijid.2021.02.046_bib0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026072","article-title":"Use of recombinant adenovirus vectored consensus IFN-\u03b1 to avert severe arenavirus infection","volume":"6","author":"Gowen","year":"2011","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.ijid.2021.02.046_bib0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002614","article-title":"Favipiravir (T-705) inhibits Jun\u00edn virus infection and reduces mortality in a guinea pig model of Argentine hemorrhagic fever","volume":"7","author":"Gowen","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"10.1016\/j.ijid.2021.02.046_bib0180","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/095632020601700402","article-title":"Combinatorial ribavirin and interferon alfacon-1 therapy of acute Arenaviral disease in Hamsters","volume":"17","author":"Gowen","year":"2006","journal-title":"Antiviral Chem Chemother"},{"key":"10.1016\/j.ijid.2021.02.046_bib0185","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.antiviral.2017.07.019","article-title":"Enhanced protection against experimental Junin virus infection through the use of a modified favipiravir loading dose strategy","volume":"145","author":"Gowen","year":"2017","journal-title":"Antiviral Res"},{"issue":"9","key":"10.1016\/j.ijid.2021.02.046_bib0190","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1128\/AAC.00356-07","article-title":"In vitro and in vivo activities of T-705 against arenavirus and bunyavirus infections","volume":"51","author":"Gowen","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.ijid.2021.02.046_bib0195","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.antiviral.2009.10.015","article-title":"Efficacy of favipiravir (T-705) and T-1106 pyrazine derivatives in phlebovirus disease models","volume":"86","author":"Gowen","year":"2010","journal-title":"Antiviral Res"},{"issue":"10","key":"10.1016\/j.ijid.2021.02.046_bib0200","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.3390\/v4102317","article-title":"Junin virus pathogenesis and virus replication","volume":"4","author":"Grant","year":"2012","journal-title":"Viruses"},{"issue":"5","key":"10.1016\/j.ijid.2021.02.046_bib0205","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1086\/514749","article-title":"Clinical case definitions for Argentine hemorrhagic fever","volume":"28","author":"Harrison","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2021.02.046_bib0210","doi-asserted-by":"crossref","first-page":"4024","DOI":"10.1128\/JVI.06397-11","article-title":"An antibody recognizing the apical domain of human transferrin receptor 1 efficiently inhibits the entry of all new world hemorrhagic fever arenaviruses","volume":"86","author":"Helguera","year":"2012","journal-title":"J Virol"},{"issue":"20","key":"10.1016\/j.ijid.2021.02.046_bib0215","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01090-17","article-title":"Highly pathogenic new world arenavirus infection activates the pattern recognition receptor protein kinase R without attenuating virus replication in human cells","volume":"91","author":"Huang","year":"2017","journal-title":"J Virol"},{"issue":"Suppl 4","key":"10.1016\/j.ijid.2021.02.046_bib0220","doi-asserted-by":"crossref","first-page":"S750","DOI":"10.1093\/clinids\/11.Supplement_4.S750","article-title":"Prospects for treatment of viral hemorrhagic fevers with ribavirin, a broad-spectrum antiviral drug","volume":"11","author":"Huggins","year":"1989","journal-title":"Rev Infect Dis"},{"issue":"6","key":"10.1016\/j.ijid.2021.02.046_bib0225","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1093\/infdis\/164.6.1119","article-title":"Prospective, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome","volume":"164","author":"Huggins","year":"1991","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.ijid.2021.02.046_bib0230","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/cmi.2016.41","article-title":"CD4 and CD8 T cells mediate distinct lethal meningoencephalitis in mice challenged with Tacaribe arenavirus","volume":"14","author":"Ireland","year":"2017","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.ijid.2021.02.046_bib0235","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/S1473-3099(15)00228-5","article-title":"Post-exposure prophylaxis against Ebola virus disease with experimental antiviral agents: a case-series of health-care workers","volume":"15","author":"Jacobs","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10.1016\/j.ijid.2021.02.046_bib0240","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1128\/AAC.29.3.521","article-title":"Effect of ribavirin and tributylribavirin on argentine hemorrhagic fever (Junin virus) in guinea pigs","volume":"29","author":"Kenyon","year":"1986","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.ijid.2021.02.046_bib0245","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/jmv.1890200303","article-title":"Treatment of junin virus-infected guinea pigs with immune serum: development of late neurological disease","volume":"20","author":"Kenyon","year":"1986","journal-title":"J Med Virol"},{"issue":"4","key":"10.1016\/j.ijid.2021.02.046_bib0250","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/clind\/24.4.718","article-title":"Treatment of Bolivian hemorrhagic fever with intravenous ribavirin","volume":"24","author":"Kilgore","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.ijid.2021.02.046_bib0255","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3201\/eid0103.950308","article-title":"Prospects for the control of Bolivian hemorrhagic fever","volume":"1","author":"Kilgore","year":"1995","journal-title":"Emerg Infect Dis"},{"issue":"8","key":"10.1016\/j.ijid.2021.02.046_bib0260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004969","article-title":"The ectodomain of glycoprotein from the candid#1 vaccine strain of Junin virus rendered Machupo virus partially attenuated in mice lacking IFN-\u03b1\u03b2\/\u03b3 receptor","volume":"10","author":"Koma","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"10.1016\/j.ijid.2021.02.046_bib0265","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1128\/JVI.02615-15","article-title":"Machupo virus expressing GPC of the Candid#1 vaccine strain of Junin virus is highly attenuated and immunogenic","volume":"90","author":"Koma","year":"2015","journal-title":"J Virol"},{"issue":"12","key":"10.1016\/j.ijid.2021.02.046_bib0270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000695","article-title":"A multivalent and cross-protective vaccine strategy against arenaviruses associated with human disease","volume":"5","author":"Kotturi","year":"2009","journal-title":"PLoS Pathogens"},{"issue":"1","key":"10.1016\/j.ijid.2021.02.046_bib0275","doi-asserted-by":"crossref","first-page":"11451","DOI":"10.1038\/s41598-018-29508-1","article-title":"Neutralization of Junin virus by single domain antibodies targeted against the nucleoprotein","volume":"8","author":"Linero","year":"2018","journal-title":"Sci Rep"},{"issue":"8894","key":"10.1016\/j.ijid.2021.02.046_bib0280","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0140-6736(94)91226-2","article-title":"New arenavirus isolated in Brazil","volume":"343","author":"Lisieux","year":"1994","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ijid.2021.02.046_bib0285","first-page":"1273","article-title":"Homologous and heterologous glycoproteins induce protection against Junin virus challenge in guinea pigs","volume":"81","author":"L\u00f3pez","year":"2000","journal-title":"J Gen Virol"},{"issue":"5\u20136","key":"10.1016\/j.ijid.2021.02.046_bib0290","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0166-3542(89)90055-7","article-title":"Arenavirus infection in the guinea pig model: antiviral therapy with recombinant interferon-alpha, the immunomodulator CL246,738 and ribavirin","volume":"12","author":"Lucia","year":"1989","journal-title":"Antiviral Res"},{"key":"10.1016\/j.ijid.2021.02.046_bib0295","article-title":"South American Hemorrhagic Fevers","author":"MacDermott","year":"2018","journal-title":"BMJ Best Pract"},{"issue":"6","key":"10.1016\/j.ijid.2021.02.046_bib0300","first-page":"523","article-title":"Possibilities for the control of hemorrhagic fevers in Latin America","volume":"62","author":"Mackenzie","year":"1967","journal-title":"Bol Oficina Sanit Panam"},{"issue":"8154","key":"10.1016\/j.ijid.2021.02.046_bib0305","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/S0140-6736(79)92335-3","article-title":"Efficacy of immune plasma in treatment of Argentine haemorrhagic fever and association between treatment and a late neurological syndrome","volume":"2","author":"Maiztegui","year":"1979","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ijid.2021.02.046_bib0310","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1086\/514211","article-title":"Protective efficacy of a live attenuated vaccine against Argentine hemorrhagic fever","volume":"177","author":"Maiztegui","year":"1998","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.ijid.2021.02.046_bib0315","doi-asserted-by":"crossref","first-page":"375","DOI":"10.12788\/jhm.3402","article-title":"The role of hospitalists in biocontainment units: a perspective","volume":"15","author":"Frank","year":"2020","journal-title":"J Hospital Med"},{"issue":"1","key":"10.1016\/j.ijid.2021.02.046_bib0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1096-8652(200005)64:1<1::AID-AJH1>3.0.CO;2-F","article-title":"Relationship between hematopoietic growth factors levels and hematological parameters in Argentine hemorrhagic fever","volume":"64","author":"Marta","year":"2000","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ijid.2021.02.046_bib0325","series-title":". The arenaviridae","first-page":"281","article-title":"The tacaribe complex: The close relationship between a pathogenic (Junin) and a nonpathogenic (Tacaribe) Arenavirus","author":"Martinez Peralta","year":"1993"},{"issue":"3","key":"10.1016\/j.ijid.2021.02.046_bib0330","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000150276","article-title":"Candid No. 1 Argentine hemorrhagic fever vaccine protects against Lethal Junin virus challenge in Rhesus Macaques","volume":"34","author":"McKee","year":"1992","journal-title":"Intervirology"},{"issue":"9","key":"10.1016\/j.ijid.2021.02.046_bib0335","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1128\/AAC.32.9.1304","article-title":"Ribavirin prophylaxis and therapy for experimental argentine hemorrhagic fever","volume":"32","author":"McKee","year":"1988","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.ijid.2021.02.046_bib0340","doi-asserted-by":"crossref","first-page":"403","DOI":"10.4269\/ajtmh.1993.48.403","article-title":"Safety and immunogenicity of a live-attenuated Junin (Argentine hemorrhagic fever) vaccine in rhesus macaques","volume":"48","author":"McKee","year":"1993","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"10.1016\/j.ijid.2021.02.046_bib0345","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1128\/AAC.01219-10","article-title":"T-705 (favipiravir) inhibition of arenavirus replication in cell culture","volume":"55","author":"Mendenhall","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.ijid.2021.02.046_bib0350","doi-asserted-by":"crossref","first-page":"554","DOI":"10.4269\/ajtmh.1994.51.554","article-title":"Prevalence of infection with Junin virus in rodent populations in the epidemic area of Argentine hemorrhagic fever","volume":"51","author":"Mills","year":"1994","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"10.1016\/j.ijid.2021.02.046_bib0355","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1017\/dmp.2014.151","article-title":"Favipiravir: a new medication for the Ebola virus disease pandemic","volume":"9","author":"Nagata","year":"2015","journal-title":"Disaster Med Public Health Preparedness"},{"key":"10.1016\/j.ijid.2021.02.046_bib0360","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.antiviral.2018.06.002","article-title":"Novel neutralizing monoclonal antibodies against Junin virus","volume":"156","author":"Pan","year":"2018","journal-title":"Antiviral Res"},{"key":"10.1016\/j.ijid.2021.02.046_bib0365","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.coviro.2014.02.007","article-title":"Epidemiology and pathogenesis of Bolivian hemorrhagic fever","volume":"5","author":"Patterson","year":"2014","journal-title":"Curr Opin Virol"},{"issue":"8","key":"10.1016\/j.ijid.2021.02.046_bib0370","doi-asserted-by":"crossref","first-page":"4940","DOI":"10.4049\/jimmunol.176.8.4940","article-title":"CpG oligodeoxynucleotides protect newborn mice from a lethal challenge with the Neurotropic Tacaribe Arenavirus","volume":"176","author":"Pedras-Vasconcelos","year":"2006","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.ijid.2021.02.046_bib0375","doi-asserted-by":"crossref","first-page":"8231","DOI":"10.4049\/jimmunol.180.12.8231","article-title":"Immunotherapy with CpG oligonucleotides and antibodies to TNF-\u03b1 rescues neonatal mice from lethal Arenavirus-Induced Meningoencephalitis","volume":"180","author":"Pedras-Vasconcelos","year":"2008","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.ijid.2021.02.046_bib0380","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0218730","article-title":"Junin virus induces autophagy in human A549 cells","volume":"14","author":"Perez Vidakovics","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2021.02.046_bib0385","first-page":"5","article-title":"Experimental studies of arenaviral hemorrhagic fevers","volume":"134","author":"Peters","year":"1987","journal-title":"Curr Top Microbiol Immunol"},{"issue":"5","key":"10.1016\/j.ijid.2021.02.046_bib0390","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1093\/cid\/cix406","article-title":"Favipiravir and ribavirin treatment of epidemiologically linked cases of lassa fever","volume":"65","author":"Raabe","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"25","key":"10.1016\/j.ijid.2021.02.046_bib0395","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1056\/NEJM199512213332516","article-title":"Laboratory-acquired Sabia virus infection","volume":"333","author":"Ryder","year":"1995","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ijid.2021.02.046_bib0400","first-page":"353","article-title":"Stability of Candid#1 vaccine to prevent Argentine Hemorrhagic Fever","volume":"77","author":"Saavedra","year":"2017","journal-title":"Medicina (B Aires)"},{"issue":"8774","key":"10.1016\/j.ijid.2021.02.046_bib0405","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/0140-6736(91)91899-6","article-title":"Venezuelan haemorrhagic fever","volume":"338","author":"Salas","year":"1991","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ijid.2021.02.046_bib0410","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1863-2378.2011.01447.x","article-title":"Effect of ribavirin on junin virus infection in guinea pigs","volume":"59","author":"Salazar","year":"2012","journal-title":"Zoonoses Public Health"},{"issue":"2","key":"10.1016\/j.ijid.2021.02.046_bib0415","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000137","article-title":"TRIM2, a novel member of the antiviral family, limits New World arenavirus entry","volume":"17","author":"Sarute","year":"2019","journal-title":"PLoS Biol"},{"issue":"1","key":"10.1016\/j.ijid.2021.02.046_bib0420","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev-virology-101416-042001","article-title":"New world arenavirus biology","volume":"4","author":"Sarute","year":"2017","journal-title":"Annu Rev Virol"},{"issue":"03","key":"10.1016\/j.ijid.2021.02.046_bib0425","first-page":"8","article-title":"identificacao de um caso de febre hemorragica brasileira no estado de sao Paulo, janeiro de 2020","volume":"51","author":"Ministerio da Saude. Secretaria de Vigilancia em Saude","year":"2020","journal-title":"Boletim Epidemiol"},{"issue":"5","key":"10.1016\/j.ijid.2021.02.046_bib0430","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/jmv.25024","article-title":"Antiviral activity of A771726, the active metabolite of leflunomide, against Junin virus","volume":"90","author":"Sepulveda","year":"2018","journal-title":"J Med Virol"},{"issue":"30","key":"10.1016\/j.ijid.2021.02.046_bib0435","doi-asserted-by":"crossref","first-page":"4713","DOI":"10.1016\/j.vaccine.2010.04.077","article-title":"TC83 replicon vectored vaccine provides protection against Junin virus in guinea pigs","volume":"28","author":"Seregin","year":"2010","journal-title":"Vaccine"},{"issue":"13","key":"10.1016\/j.ijid.2021.02.046_bib0440","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00482-18","article-title":"Arenaviral nucleoproteins suppress PACT-induced Augmentation of RIG-I function to inhibit type I interferon production","volume":"92","author":"Shao","year":"2018","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.ijid.2021.02.046_bib0445","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3390\/pathogens4020283","article-title":"Human hemorrhagic fever causing arenaviruses: molecular mechanisms contributing to virus virulence and disease pathogenesis","volume":"4","author":"Shao","year":"2015","journal-title":"Pathogens"},{"issue":"3","key":"10.1016\/j.ijid.2021.02.046_bib0450","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001967","article-title":"Experimental treatment with favipiravir for Ebola virus disease (the JIKI Trial): a historically controlled, single-arm proof-of-concept trial in guinea","volume":"13","author":"Sissoko","year":"2016","journal-title":"PLoS Med"},{"issue":"1","key":"10.1016\/j.ijid.2021.02.046_bib0455","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0166-3542(93)90059-R","article-title":"Treatment of lethal Pichinde virus infections in weanling LVG\/Lak hamsters with ribavirin, ribamidine, selenazofurin, and ampligen","volume":"20","author":"Smee","year":"1993","journal-title":"Antiviral Res"},{"issue":"4","key":"10.1016\/j.ijid.2021.02.046_bib0460","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1089\/bsp.2006.4.351","article-title":"Designing a biocontainment unit to care for patients with serious communicable diseases: a consensus statement","volume":"4","author":"Smith","year":"2006","journal-title":"Biosecur Bioterror"},{"key":"10.1016\/j.ijid.2021.02.046_bib0465","series-title":"Ribavirin treatment of toga-, arena-, and bunyavirus infections in subhuman primates and other laboratory animal species. Ribavirin \u2013 a broad spectrum antiviral agent","first-page":"169","author":"Stephen","year":"1980"},{"key":"10.1016\/j.ijid.2021.02.046_bib0470","series-title":"ICTV virus taxonomy, Genus: mammarenavirus. ICTV Online Report. 10th report","author":"Viruses","year":"2018"},{"issue":"2","key":"10.1016\/j.ijid.2021.02.046_bib0475","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1128\/iai.35.2.425-430.1982","article-title":"Cross-protection in nonhuman primates against Argentine hemorrhagic fever","volume":"35","author":"Weissenbacher","year":"1982","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.ijid.2021.02.046_bib0480","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/jmv.1890120407","article-title":"Junin virus activity in two rural populations of the Argentine hemorrhagic fever (AHF) endemic area","volume":"12","author":"Weissenbacher","year":"1983","journal-title":"J Med Virol"},{"key":"10.1016\/j.ijid.2021.02.046_bib0485","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.antiviral.2015.12.006","article-title":"Low-dose ribavirin potentiates the antiviral activity of favipiravir against hemorrhagic fever viruses","volume":"126","author":"Westover","year":"2016","journal-title":"Antiviral Res"},{"issue":"1","key":"10.1016\/j.ijid.2021.02.046_bib0490","doi-asserted-by":"crossref","DOI":"10.1186\/s12985-018-1009-4","article-title":"Description and characterization of a novel live-attenuated tri-segmented Machupo virus in Guinea pigs","volume":"15","author":"Zaza","year":"2018","journal-title":"Virol J"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971221001326?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971221001326?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T08:01:31Z","timestamp":1761120091000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971221001326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":98,"alternative-id":["S1201971221001326"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2021.02.046","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"South American Hemorrhagic Fevers: A summary for clinicians","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2021.02.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}